Indiana Health Coverage Programs (IHCP) is updating long-acting reversible contraceptive (LARC) coverage to comply with Indiana Code IC-12-15-47. 
 
Under IC-12-15-47, for which ISMA advocated during the 2023 session, LARC intrauterine devices and birth control implants obtained for a Medicaid recipient may be transferred to another Medicaid recipient if the LARC was not delivered to, implanted in or used on the original Medicaid recipient to whom the LARC was prescribed if the LARC product meets the following conditions:

• Be in the original, unopened package.
• Have been in the possession of the provider for at least 12 weeks. However, the requirement under this subdivision may be waived by the written consent of the original Medicaid recipient to whom the LARC was prescribed.
• Not have left the possession of the provider that originally prescribed the LARC.
• Be medically appropriate and not contraindicated for the Medicaid recipient to whom the LARC is being transferred.

For dates of service on or after Oct. 1, 2023, IHCP will reimburse LARC claims through the pharmacy benefit for IHCP-enrolled pharmacies only if they meet the resale, reuse or redistribution requirements outlined in IC 25-26-13-25. Claims for transferred LARC products will need to be reversed for the original Medicaid recipient and resubmitted for the Medicaid recipient to whom the product is being transferred. 
 
Pharmacy providers not meeting IC 25-26-13-25 requirements for dispensing returned products will no longer be reimbursed for LARC claims. The IHCP will continue reimbursing IHCP-enrolled providers for LARC claims submitted through the medical benefit. 
 
 Learn more in IHCOP BT 2023111.